| 发明名称 |
METHOD OF EVALUATING PANCREATIC CANCER, PANCREATIC CANCER-EVALUATING APPARATUS, PANCREATIC CANCER-EVALUATING METHOD, PANCREATIC CANCER-EVALUATING PROGRAM PRODUCT, PANCREATIC CANCER-EVALUATING SYSTEM, AND INFORMATION COMMUNICATION TERMINAL APPARATUS |
| 摘要 |
A method of evaluating pancreatic cancer includes (I) an obtaining step of obtaining amino acid concentration data on a concentration value of an amino acid in blood collected from a subject to be evaluated, and (II) an evaluating step of evaluating a state of pancreatic cancer in the subject by calculating a value of a formula using the amino acid concentration data of the subject obtained at the obtaining step and the formula previously established for evaluating the state of pancreatic cancer, including an explanatory variable to be substituted with the concentration value of the amino acid. The amino acid concentration data includes the concentration values of at least two amino acids of Asn, His, Thr, Ala, Cit, Arg, Tyr, Val, Met, Lys, Trp, Gly, Pro, Orn, Ile, Leu, Phe, Ser, and Gln, and the formula includes at least two explanatory variables to be substituted with the concentration values of at least two amino acids of Asn, His, Thr, Ala, Cit, Arg, Tyr, Val, Met, Lys, Trp, Gly, Pro, Orn, Ile, Leu, Phe, Ser, and Gln. |
| 申请公布号 |
US2015254411(A1) |
申请公布日期 |
2015.09.10 |
| 申请号 |
US201514721439 |
申请日期 |
2015.05.26 |
| 申请人 |
Ajinomoto Co., Inc. |
发明人 |
Ono Nobukazu;Shinhara Atsuko;Muramatsu Takahiko;Kikuchi Shinya;Yamamoto Hiroshi;Shiraishi Koichi;Katayama Kazuhiro;Fukutake Nobuyasu;Higashiyama Masahiko;Ohkawa Shinichi;Ueno Makoto;Miyagi Yohei;Okamoto Naoyuki |
| 分类号 |
G06F19/00 |
主分类号 |
G06F19/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of evaluating pancreatic cancer, comprising:
an obtaining step of obtaining amino acid concentration data on a concentration value of an amino acid in blood collected from a subject to be evaluated; and an evaluating step of evaluating a state of pancreatic cancer in the subject by calculating a value of a formula using (i) the amino acid concentration data of the subject obtained at the obtaining step and (ii) the formula previously established for evaluating the state of pancreatic cancer, including an explanatory variable to be substituted with the concentration value of the amino acid, wherein the amino acid concentration data includes the concentration values of at least two amino acids of Asn, His, Thr, Ala, Cit, Arg, Tyr, Val, Met, Lys, Trp, Gly, Pro, Orn, Ile, Leu, Phe, Ser, and Gln, and the formula includes at least two explanatory variables to be substituted with the concentration values of at least two amino acids of Asn, His, Thr, Ala, Cit, Arg, Tyr, Val, Met, Lys, Trp, Gly, Pro, Orn, Ile, Leu, Phe, Ser, and Gln. |
| 地址 |
Tokyo JP |
